Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Fink

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|December 18, 2007
Long-term maternal imprinting of the specific B cell repertoire by maternal antibodiesKatja Fink, Raphael Zellweger, Jacqueline Weber, et al.
Plos Pathogens|December 5, 2014
Selective susceptibility of human skin antigen presenting cells to productive dengue virus infectionDaniela Cerny, Muzlifah Haniffa, Amanda Shin, et al.
Frontiers in Immunology|July 9, 2019
Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in MiceJue Hou, Shubham Shrivastava, Christopher C Fraser, et al.
Plos One|May 18, 2023
A nonstructural protein 1 capture enzyme-linked immunosorbent assay specific for dengue virusesPei-Yin Lim, Appanna Ramapraba, Thomas Loy, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesSumathy Velumani, Ying Xiu Toh, Shobana Balasingam, et al.
Plos Pathogens|September 3, 2010
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humansElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Journal of Virology|April 18, 2014
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccinesRoland Züst, Ying-Xiu Toh, Iris Valdés, et al.
NPJ Vaccines|December 22, 2017
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virusMeihui Xu, Roland Zuest, Sumathy Velumani, et al.
Journal of Virology|May 3, 2019
RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing CytotoxicityVictor Ho, Hui Yee Yong, Marion Chevrier, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|July 6, 2012
Electrochemical impedance spectroscopy characterization of nanoporous alumina dengue virus biosensorBinh Thi Thanh Nguyen, Alister En Kai Peh, Celine Yue Ling Chee, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|December 18, 2007
Long-term maternal imprinting of the specific B cell repertoire by maternal antibodiesKatja Fink, Raphael Zellweger, Jacqueline Weber, et al.
Plos Pathogens|December 5, 2014
Selective susceptibility of human skin antigen presenting cells to productive dengue virus infectionDaniela Cerny, Muzlifah Haniffa, Amanda Shin, et al.
Frontiers in Immunology|July 9, 2019
Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in MiceJue Hou, Shubham Shrivastava, Christopher C Fraser, et al.
Plos One|May 18, 2023
A nonstructural protein 1 capture enzyme-linked immunosorbent assay specific for dengue virusesPei-Yin Lim, Appanna Ramapraba, Thomas Loy, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesSumathy Velumani, Ying Xiu Toh, Shobana Balasingam, et al.
Plos Pathogens|September 3, 2010
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humansElena Sandalova, Diletta Laccabue, Carolina Boni, et al.
Journal of Virology|April 18, 2014
Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccinesRoland Züst, Ying-Xiu Toh, Iris Valdés, et al.
NPJ Vaccines|December 22, 2017
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virusMeihui Xu, Roland Zuest, Sumathy Velumani, et al.
Journal of Virology|May 3, 2019
RIG-I Activation by a Designer Short RNA Ligand Protects Human Immune Cells against Dengue Virus Infection without Causing CytotoxicityVictor Ho, Hui Yee Yong, Marion Chevrier, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|July 6, 2012
Electrochemical impedance spectroscopy characterization of nanoporous alumina dengue virus biosensorBinh Thi Thanh Nguyen, Alister En Kai Peh, Celine Yue Ling Chee, et al.
Pageof 9